← back to search

Heyang Cui

Shanxi Medical University · CN
Area of research
Molecular Biology · Surgery
Research interest
Research interests include Esophageal Cancer Research and Treatment, Cancer-related gene regulation, RNA modifications and cancer, and Cancer Genomics and Diagnostics.
h-index
20
citations
1,935
works
53
NIH funding
primary concept
Biology
email

Recent publications

Multi-omics analysis reveals immunosuppression in oesophageal squamous cell carcinoma induced by creatine accumulation and HK3 deficiency
Genome Medicine 2025cited by 7position: middledoi
Immune-tumor interaction dictates spatially directed evolution of esophageal squamous cell carcinoma
National Science Review 2024cited by 18position: middledoi
Leveraging new methods for comprehensive characterization of mitochondrial DNA in esophageal squamous cell carcinoma
Genome Medicine 2024cited by 11position: middledoi
Fusobacterium nucleatum Infection Induces Malignant Proliferation of Esophageal Squamous Cell Carcinoma Cell by Putrescine Production
Microbiology Spectrum 2023cited by 28position: middledoi
IGH repertoire analysis at scale: deciphering the complexity of B cell infiltration and migration in esophageal squamous cell carcinoma
Cancer Gene Therapy 2023cited by 2position: middledoi
Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma
Cancer Cell 2022cited by 170position: middledoi
Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma
Nature Communications 2022cited by 21position: firstdoi
An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma
Journal of Translational Medicine 2022cited by 11position: middledoi
Author Correction: Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Cell Research 2022cited by 6position: middledoi
CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
Frontiers in Oncology 2021cited by 20position: middledoi
Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma
Cell Research 2020cited by 317position: middledoi
Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma
Cell Death and Disease 2020cited by 50position: middledoi
Elevated DHODH expression promotes cell proliferation via stabilizing β-catenin in esophageal squamous cell carcinoma
Cell Death and Disease 2020cited by 38position: middledoi
Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC
Theranostics 2020cited by 37position: middledoi
TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
Theranostics 2020cited by 22position: middledoi
Corrigendum to “FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer” [Canc. Lett. 397 (2017) 83–93]
Cancer Letters 2020cited by 7position: middledoi
Author Correction: Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2020cited by 6position: middledoi
Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
Technology in Cancer Research & Treatment 2020cited by 5position: middledoi
Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma
Nature Communications 2019cited by 149position: middledoi
EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
Journal of Cancer 2019cited by 51position: middledoi
FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma
Oncology Reports 2018cited by 27position: middledoi
High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC
Technology in Cancer Research & Treatment 2018cited by 16position: middledoi
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer
Cancer Letters 2017cited by 104position: middledoi
Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
The American Journal of Human Genetics 2016cited by 146position: middledoi
Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
GigaScience 2016cited by 87position: middledoi
Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
The American Journal of Human Genetics 2015cited by 342position: middledoi
Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma
Oncology Letters 2015cited by 31position: middledoi
Mutually exclusive mutations in<i>NOTCH1</i>and<i>PIK3CA</i>associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China
Oncotarget 2015cited by 26position: middledoi
Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
Cancer Letters 2013cited by 16position: middledoi
Phosphorylation of Mps1 by BRAFV600E prevents Mps1 degradation and contributes to chromosome instability in melanoma
Oncogene 2012cited by 37position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yongping Cui · Shanxi Medical University12 papers (2012–2024)Pengzhou Kong · Shanxi Medical University8 papers (2018–2025)Yanghui Bi · Shanxi Medical University8 papers (2013–2021)Xiaolong Cheng · Shanxi Medical University6 papers (2020–2025)Ting Yan · Shanxi Medical University6 papers (2018–2024)Yikun Cheng · University of California, Berkeley6 papers (2020–2025)Ling Zhang · Harbin Medical University6 papers (2018–2025)Yu Qian · Jiangnan University5 papers (2018–2020)Yanchun Ma · Shanxi Medical University5 papers (2018–2022)Caixia Cheng · Shanxi Medical University5 papers (2013–2021)Enwei Xu · Shanxi Provincial Cancer Hospital5 papers (2020–2025)Xiaolong Cheng · Shanxi Medical University5 papers (2012–2024)Yuanfang Zhai · Ministry of Education of the People's Republic of China4 papers (2018–2025)Bin Song · Shanghai Medical College of Fudan University4 papers (2013–2020)Yongping Cui · Shanxi Medical University3 papers (2023–2025)Yong Zhou · University of Edinburgh3 papers (2023–2024)Weimin Zhang · Dalian Medical University3 papers (2023–2024)Hongyi Li · Beijing University of Technology3 papers (2020–2021)Yongsheng Meng · Shanxi Medical University3 papers (2021–2025)Jian Yang · Tianjin University of Traditional Chinese Medicine3 papers (2020–2020)